SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $113 million in its first quarter.

The San Carlos, California-based company said it had a loss of 42 cents per share.

The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.

The biotechnology company posted revenue of $715,000 in the period, falling short of Street forecasts. Six analysts surveyed by Zacks expected $2.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News